Open Access

Non-contiguous finished genome sequence and description of Brevibacillus massiliensis sp. nov.

  • Perrine Hugon
  • , Ajay Kumar Mishra
  • , Jean-Christophe Lagier
  • , Thi Thien Nguyen
  • , Carine Couderc
  • , Didier Raoult
  • and Pierre-Edouard Fournier
Corresponding author

DOI: 10.4056/sigs.3466975

Received: 15 April 2013

Accepted: 15 April 2013

Published: 15 April 2013

Abstract

Brevibacillus massiliensis strain phRT sp. nov. is the type strain of B. massiliensis sp. nov., a new species within the genus Brevibacillus. This strain was isolated from the fecal flora of a woman suffering from morbid obesity. B. massiliensis is a Gram-positive aerobic rod-shaped bacterium. Here we describe the features of this organism, together with the complete genome sequence and annotation. The 5,051,018 bp long genome (1 chromosome but no plasmid) contains 5,051 protein-coding and 84 RNA genes, and exhibits a G+C content of 53.1%.

Keywords:

Brevibacillus massiliensisgenomeculturomicstaxono-genomics

Introduction

Brevibacillus massiliensis strain phRT (= CSUR P177 = DSM 25447) is the type strain of B. massiliensis sp. nov. This bacterium is a Gram-positive, spore-forming, indole negative, aerobic and motile bacillus that was isolated from the stool of a 26-year-old woman suffering from morbid obesity. The strain was isolated as part of a study aiming at individually cultivating all species within human feces [1]. The current approach to classification of prokaryotes, often referred to as polyphasic taxonomy, relies on a combination of phenotypic and genotypic characteristics [2]. However, as more than 3,000 bacterial genomes have been sequenced to date [3] and the cost of genomic sequencing is decreasing, we recently proposed to integrate genomic information in the description of new bacterial species [4-15].

The genus Brevibacillus (Shilda et al. 1996) was created in 1996 by reclassification of 10 Bacillus species, on the basis of 16S rDNA gene sequence analysis [16]. To date, this genus is made of 18 species [17], including B. agri, B. brevis, B. centrosporus, B. choshinensis, B. parabrevis, B. reuszeri, B. formosus, B. borstelensis, B. laterosporus, and B. thermoruber [16], B. invocatus [18], B. limnophilus [19], B. levickii [20], B. ginsengisoli [21], B. panacihumi in [22], B. fluminis in [23], and B. nitrificans [24]. Members of the genus Brevibacillus are environmental bacteria and were mostly isolated from soil [22,25]. In addition, B. brevis and B. centrosporus were isolated from indoor dust in schools, day care centers for children and animal sheds [26], and fecal flora of children, respectively [27]. However, several Brevibacillus species are also frequently isolated from humans, notably in nosocomial infections, causing breast abscess, pneumonia [18], peritonitis [28] and endopthalmitis [29].

Here we present a summary classification and a set of features for B. massiliensis sp. nov. strain phRT (= CSUR P177 = DSM 25447), together with the description of the complete genomic sequencing and annotation. These characteristics support the circumscription of the B. massiliensis species.

Classification and features

A stool sample was collected from a 26-year-old woman living in Marseille (France). She suffered from morbid obesity and had a body mass index of 48.2 (118.8 kg, 1.57 meter). At the time of stool sample collection she was not under medication or on a diet. The patient gave an informed and signed consent. This study and the assent procedure were approved by the Ethics Committee of the Institut Fédératif de Recherche IFR48, Faculty of Medicine, Marseille, France (agreement 11-017). The fecal specimen was preserved at -80°C after collection. Strain phRT (Table 1) was isolated in 2011 by aerobic cultivation on M17 agar medium (Oxoid, Basingstoke, England).

Table 1

Classification and general features of Brevibacillus massiliensis strain phRT according to the MIGS recommendations [42]

MIGS ID

   Property

   Term

   Evidence codea

   Domain Bacteria

   TAS [30]

   Phylum Firmicutes

   TAS [31-33]

   Class Bacilli

   TAS [34,35]

   Current classification

   Order Bacillales

   TAS [36,37]

   Family Paenibacillaceae

   TAS [34,38]

   Genus Brevibacillus

   TAS [16]

   Species Brevibacillus massiliensis

   IDA

   Type strain phRT

   IDA

   Gram stain

   positive

   IDA

   Cell shape

   rod

   IDA

   Motility

   motile

   IDA

   Sporulation

   sporulating

   IDA

   Temperature range

   mesophile

   IDA

   Optimum temperature

   37°C

   IDA

MIGS-6.3

   Salinity

   growth in BHI medium + 5% NaCl

   IDA

MIGS-22

   Oxygen requirement

   aerobic

   IDA

   Carbon source

   unknown

   Energy source

   unknown

MIGS-6

   Habitat

   human gut

   IDA

MIGS-15

   Biotic relationship

   free living

   IDA

MIGS-14

   Pathogenicity   Biosafety level   Isolation

   unknown   2   human feces

MIGS-4

   Geographic location

   France

   IDA

MIGS-5

   Sample collection time

   January 2011

   IDA

MIGS-4.1

   Latitude

   43.296482

   IDA

MIGS-4.2

   Longitude

   5.36978

   IDA

MIGS-4.3

   Depth

   surface

   IDA

MIGS-4.4

   Altitude

   0 m above sea level

   IDA

Evidence codes - IDA: Inferred from Direct Assay; TAS: Traceable Author Statement (i.e., a direct report exists in the literature); NAS: Non-traceable Author Statement (i.e., not directly observed for the living, isolated sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence codes are from the Gene Ontology project [39]. If the evidence is IDA, then the property was directly observed for a live isolate by one of the authors or an expert mentioned in the acknowledgements.

This strain exhibited a nucleotide sequence similarity with Brevibacillus species ranging from 94% with B. centrosporus [18] to 96% with B. reuszeri, B. parabrevis, B. invocatus, B. brevis, B. borstelensis [18], B. panacihumi [22], B. levickii [20], (Figure 1). This latter value was lower than the 98.7% 16S rRNA gene sequence threshold recommended by Stackebrandt and Ebers to delineate a new species without carrying out DNA-DNA hybridization [40].

Figure 1

Phylogenetic tree highlighting the position of Brevibacillus massiliensis strain phRT relative to other type strains within the Brevibacillus genus. GenBank accession numbers are indicated in parentheses. Sequences were aligned using CLUSTALW, and phylogenetic inferences obtained using the maximum-likelihood method within MEGA program. Numbers at the nodes are percentages of bootstrap values obtained by repeating the analysis 500 times to generate a majority consensus tree. Alicyclobacillus acidocaldarius was used as outgroup. The scale bar represents a 2% nucleotide sequence divergence.

Different growth temperatures (25, 30, 37, 45°C [Table 2]) were tested; no growth occurred at 25°C, growth occurred between 30 and 45°C, and optimal growth was observed at 37°C. Grey colonies were 0.8 mm to 1 mm in diameter on blood-enriched Columbia agar and Brain Heart Infusion (BHI) agar. Growth of the strain was tested under anaerobic and microaerophilic conditions using GENbag anaer and GENbag microaer systems, respectively (BioMerieux), and in the presence of air, with or without 5% CO2. Growth was obtained aerobically. A weak growth was observed with 5% CO2, but no growth occurred in microaerophilic and anaerobic conditions. Gram staining showed Gram-positive rods (Figure 2). The motility test was positive. Cell diameters ranged from 0.61 µm to 0.80 µm, with a mean diameter of 0.74 µm, and from 2.60µm to 7.30 µm long, with a mean length of 4.3µm in electron microscopy. Peritrichous flagellae were also observed (Figure 3).

Table 2

Differential characteristics of B. massiliensis sp. nov strain ph1T, B. agri strain NRRL NRS-1219, B. laterosporus strain JCM 2496 and B. brevis NBRC 15304T.

Properties

    B.massiliensis

    B.agri

    B.laterosporus

     B.brevis

Cell diameter (µm)

    0.74

    0.75

    na

     0.50

Oxygen requirement

    aerobic

    aerobic

    aerobic, facultative anaerobic

     aerobic

Gram stain

    +

    +

    var

     +

Salt requirement

    na

    na

    na

     -

Motility

    +

    +

    +

     +

Endospore formation

    na

    +

    +

     +

Production of

Alkaline phosphatase

    +

    na

    na

     -

Acid phosphatase

    +

    na

    na

     -

Catalase

    +

    +

    +

     +

Oxidase

    +

    -

    na

     +

Nitrate reductase

    -

    -

    na

     +

Urease

    -

    -

    na

     -

α-galactosidase

    -

    na

    na

     -

β- galactosidase

    -

    na

    na

     -

β-glucuronidase

    -

    na

    na

     -

α -glucosidase

    -

    na

    na

     -

N-acetyl- β -glucosamidase

    -

    na

    na

     -

Indole

    -

    -

    -

     -

Esterase

    w

    na

    na

     +

Esterase lipase

    w

    na

    na

     +

Naphthyl-AS-BI-phosphohydrolase

    +

    na

    na

     +

Arginine arylamidase

    -

    na

    na

     na

Arginine dihydrolase

    -

    na

    na

     -

Glutamyl glutamic acidarylamidase

    -

    na

    na

     na

Phenylalanine arylamidase

    -

    na

    na

     na

Leucine arylamidase

    w

    na

    na

     -

Cystine arylamidase

    +

    na

    na

     -

Valine arylamidase

    w

    na

    na

     -

Glycine arylamidase

    -

    na

    na

     na

Histidine arylamidase

    -

    na

    na

     na

Serine arylamidase

    -

    na

    na

     na

Utilization of

D-mannose

    -

    na

    na

     -

Habitat

    human gut

    environment

    environment

     environment

Figure 2

Gram staining of B. massiliensis strain phRT

Figure 3

Transmission electron microscopy of B. massiliensis strain phRT, using a Morgani 268D (Philips) at an operating voltage of 60kV. The scale bar represents 1 µm.

Strain phRT exhibited catalase and oxidase activities. Using an API ZYM strip (BioMerieux, Marcy l’Etoile), positive reactions were obtained for alkaline phosphatase, cystine arylamidase, acid phosphatase and naphtol-AS-BI-phosphohydrolase. Weak reactions were obtained for esterase, esterase lipase, leucine arylamidase, valine arylamidase, and α-chymotrypsin. Using an API Coryne strip (BioMerieux), positive reactions were obtained for pyrazinamidase and alkaline phosphatase. No sugar fermentation was observed using API 50CH (Biomerieux).

B. massiliensis is susceptible to penicillin G, amoxicillin, amoxicillin + clavulanic acid, ceftriaxon, imipenem, erythromycin, doxycyclin, rifampicine, vancomycin, ciprofloxacin, gentamicin, nitrofurantoin and resistant to metronidazole and trimetoprim + sulfamethoxazole. By comparison with B. borstelensis, its phylogenetically-closest neighbor, B. massiliensis differed in fumarate, phenylacetate and glutamate activities [18]. By comparison with B. brevis, B.massiliensis differed in alkaline and acid phosphatase production, nitrate reductase, esterase, esterase lipase, leucine arylamidase, cystine arylamidase and valine arylamidase production. By comparison with B. agri, B. massiliensis differed in oxidase production.

Matrix-assisted laser-desorption/ionization time-of-flight (MALDI-TOF) MS protein analysis was carried out as previously described [41]. Briefly, a pipette tip was used to pick an isolated bacterial colony from a culture agar plate and spread it as a thin film on a MTP 384 MALDI-TOF target plate (Bruker Daltonics, Germany). Twelve distinct deposits were done for strain phRT from twelve isolated colonies. Each smear was overlaid with 2µL of matrix solution (saturated solution of alpha-cyano-4-hydroxycinnamic acid) in 50% acetonitrile, 2.5% tri-fluoracetic acid, and allowed to dry for five minutes. Measurements were performed with a Microflex spectrometer (Bruker). Spectra were recorded in the positive linear mode for the mass range of 2,000 to 20,000 Da (parameter settings: ion source 1 (ISI), 20kV; IS2, 18.5 kV; lens, 7 kV). A spectrum was obtained after 675 shots at a variable laser power. The time of acquisition was between 30 seconds and 1 minute per spot. The twelve phRT spectra were imported into the MALDI BioTyper software (version 2.0, Bruker) and analyzed by standard pattern matching (with default parameter settings) against the main spectra of 3,769 bacteria, including spectra from nine validly published Brevibacillus species that were used as reference data in the BioTyper database (updated March 15th, 2012). The method of identification includes the m/z from 3,000 to 15,000 Da. For every spectrum, 100 peaks at most were taken into account and compared with the spectra in the database. A score enabled the presumptive identification and discrimination of the tested species from those in a database: a score > 2 with a validated species enabled the identification at the species level; a score > 1.7 but < 2 enabled the identification at the genus level; and a score < 1.7 did not enable any identification. For strain phRT, no significance score was obtained, thus suggesting that our isolate was not a member of a known species. We incremented our database with the spectrum from strain phRT (Figure 4). Finally, the gel view allows us to highlight the spectra differences with other of Brevibacillus genera members (Figure 5).

Figure 4

Reference mass spectrum from B. massiliensis strain phRT. Spectra from 12 individual colonies were compared and a reference spectrum was generated.

Figure 5

Gel view comparing Brevibacillus massiliensis phRT spectra with other members into Brevibacillus genera (Brevibacillus reuszeri, Brevibacillus parabrevis, Brevibacillus laterosporus, Brevibacillus formosus, Brevibacillus choshinensis, Brevibacillus centrosporus, Brevibacillus brevis, Brevibacillus borstelensis, Brevibacillus agri). The Gel View displays the raw spectra of all loaded spectrum files arranged in a pseudo-gel like look. The x-axis records the m/z value. The left y-axis displays the running spectrum number originating from subsequent spectra loading. The peak intensity is expressed by a Gray scale scheme code. The color bar and the right y-axis indicates the relation between the color a peak is displayed with and the peak intensity in arbitrary units.

Genome sequencing information

Genome project history

The organism was selected for sequencing on the basis of its phylogenetic position and 16S rRNA similarity to other members of the Brevibacillus genus, and is part of a study of the human digestive flora aiming at isolating all bacterial species within human feces. It was the fifth genome of a Brevibacillus species and the first genome of Brevibacillus massiliensis sp. nov. The Genbank accession number is CAGW00000000 and consists of 132 contigs. Table 3 shows the project information and its association with MIGS version 2.0 compliance [42].

Table 3

Project information

MIGS ID

     Property

     Term

MIGS-31

     Finishing quality

     High-quality draft

MIGS-28

     Libraries used

     One 454 paired end 3-kb library

MIGS-29

     Sequencing platforms

     454 GS FLX Titanium

MIGS-31.2

     Fold coverage

     54.2×

MIGS-30

     Assemblers

     Newbler version 2.5.3

MIGS-32

     Gene calling method

     Prodigal

     INSDC ID

     PRJEA82077

     Genbank ID

     CAGW00000000

     Genbank Date of Release

      May 30, 2012

     Project relevance

     Study of the human gut microbiome

Growth conditions and DNA isolation

B. massiliensis sp. nov. strain phRT, (= CSUR P177 = DSM 25447), was grown aerobically on M17 agar medium at 37°C. Five petri dishes were spread and resuspended in 3×100µl of G2 buffer (EZ1 DNA Tissue kit, Qiagen). A first mechanical lysis was performed using glass powder on a Fastprep-24 device (Sample Preparation system, MP Biomedicals, USA) during 2×20 seconds. DNA was then treated with 2.5 µg/µL (30 minutes at 37°C) and extracted using a BioRobot EZ 1 Advanced XL (Qiagen). The DNA was then concentrated and purified on a Qiamp kit (Qiagen). The yield and the concentration was measured by the Quant-it Picogreen kit (Invitrogen) on the Genios_Tecan fluorometer at 36.8 ng/µl.

Genome sequencing and assembly

A 3kb paired-end sequencing strategy (Roche, Meylan, France) was used. Five µg of DNA was mechanically fragmented on the Hydroshear device (Digilab, Holliston, MA,USA) with an enrichment size at 3-4kb. The DNA fragmentation was visualized through an Agilent 2100 BioAnalyzer on a DNA labchip 7500 with an optimal size of 3.2 kb. The library was constructed according to the 454 GS FLX Titanium paired end protocol. Circularization and nebulization were performed and generated a pattern with an optimal at 555 bp. After PCR amplification through 17 cycles followed by double size selection, the single stranded paired-end library was then quantified on the Quant-it Ribogreen kit (Invitrogen) on the Genios_Tecan fluorometer at 21 pg/µL. The library concentration equivalence was calculated as 6.94e+07 molecules/µL. The library was stored at -20°C until further use.

The 3kb paired-end library was amplified in 9 emPCR reactions at 1cpb, and in 2 emPCRs at 0.5 cpb with the GS Titanium SV emPCR Kit (Lib-L) v2 (Roche).The yield of the 2 types of paired-end emPCR reactions was 7.8% and 11.2%, respectively, in the quality range of 5 to 20% expected from the Roche procedure. Both libraries were loaded onto GS Titanium PicoTiterPlates (PTP Kit 70×75, Roche) and pyrosequenced with the GS Titanium Sequencing Kit XLR70 and the GS FLX Titanium sequencer (Roche).The run was performed overnight and then analyzed on the cluster through the gsRunBrowser and Newbler assembler (Roche). A total of 969,014 passed filter wells were obtained and generated 274 Mb with a length average of 286 bp. The passed filter sequences were assembled using Newbler with 90% identity and 40bp as overlap. The final assembly identified 31 scaffolds and 129 contigs (>1,500 bp) and generated a genome size of 5.05Mb, which corresponds to a coverage of 54.2× coverage.

Genome annotation

Open Reading Frames (ORFs) were predicted using Prodigal [43] with default parameters but the predicted ORFs were excluded if they spanned a sequencing gap region. The predicted bacterial protein sequences were searched against the GenBank database [44] and the Clusters of Orthologous Groups (COG) databases using BLASTP. The tRNAScanSE tool [45] was used to find tRNA genes, whereas ribosomal RNAs were found by using RNAmmer [46] and BLASTN against the GenBank database. Lipoprotein signal peptides and numbers of transmembrane helices were predicted using SignalP [47] and TMHMM [48], respectively. ORFans were identified if their BLASTP E-value was lower than 1e-03 for alignment length greater than 80 amino acids. If alignment lengths were smaller than 80 amino acids, we used an E-value of 1e-05. Such parameter thresholds have already been used in previous works to define ORFans. To estimate the mean level of nucleotide sequence similarity at the genome level between B. massiliensis strain phRT, B. laterosporus strain LMG15441 (GenBank accession number AFRV00000000) and B. brevis strain NBRC100599 (GenBank accession number AP008955) and B. agri strain BAB-2500, we compared genomes two by two and determined the mean percentage of nucleotide sequence identity among orthologous ORFs using BLASTn. Orthologous genes were detected using the Proteinortho software [49].

Genome properties

The genome of B. massiliensis strain phRT is 5,051,018 bp long (1 chromosome but no plasmid) with a G + C content of 53.1% (Figure 6 and Table 4). Of the 5,135 predicted genes, 5,051 were protein-coding genes, and 84 were RNAs. Three rRNA genes (one 16S rRNA, one 23S rRNA and one 5S rRNA) and 81 predicted tRNA genes were identified in the genome. A total of 3,793 genes (73.86%) were assigned a putative function. Three hundred and seventy-eight genes were identified as ORFans (7.36%). The remaining genes were annotated as hypothetical proteins. The properties and the statistics of the genome are summarized in Table 4. The distribution of genes into COGs functional categories is presented in Table 5.

Figure 6

Graphical circular map of the chromosome. From the outside in, the outer two circles shows open reading frames oriented in the forward (colored by COG categories) and reverse (colored by COG categories) direction, respectively. The third circle marks the rRNA gene operon (red) and tRNA genes (green). The fourth circle shows the G+C% content plot. The inner-most circle shows GC skew, purple indicating negative values whereas olive for positive values.

Table 4

Nucleotide content and gene count levels of the genome

Attribute

   Value

   % of totala

Genome size (bp)

   5,051,018

DNA coding region (bp)

   4,481,706

   88.72

DNA G+C content (bp)

   2,682,091

   53.10

Number of replicons

   1

Extrachromosomal elements

   0

Total genes

   5,135

   100

RNA genes

   84

   1.63

rRNA operons

   1

Protein-coding genes

   5,051

   98.36

Genes with function prediction

   4,198

   81.75

Genes assigned to COGs

   3,793

   73.86

Genes with peptide signals

   354

   6.89

Genes with transmembrane helices

   1,277

   24.86

CRISPR repeats

   0

a The total is based on either the size of the genome in base pairs or the total number of protein coding genes in the annotated genome

Table 5

Number of genes associated with the 25 general COG functional categories

Code

   Value

   %agea

    Description

J

   165

   3.27

    Translation

A

   0

   0

    RNA processing and modification

K

   405

   8.0

    Transcription

L

   176

   3.48

    Replication, recombination and repair

B

   1

   0.02

    Chromatin structure and dynamics

D

   33

   065

    Cell cycle control, mitosis and meiosis

Y

   0

   0

    Nuclear structure

V

   50

   0.99

    Defense mechanisms

T

   233

   4.61

    Signal transduction mechanisms

M

   181

   3.58

    Cell wall/membrane biogenesis

N

   60

   1.19

    Cell motility

Z

   0

   0

    Cytoskeleton

W

   0

   0

    Extracellular structures

U

   42

   0.83

    Intracellular trafficking and secretion

O

   111

   2.20

    Posttranslational modification, protein turnover, chaperones

C

   251

   4.97

    Energy production and conversion

G

   327

   6.47

    Carbohydrate transport and metabolism

E

   700

   13.86

    Amino acid transport and metabolism

F

   88

   1.74

    Nucleotide transport and metabolism

H

   159

   3.15

    Coenzyme transport and metabolism

I

   171

   3.39

    Lipid transport and metabolism

P

   317

   6.28

    Inorganic ion transport and metabolism

Q

   150

   2.97

    Secondary metabolites biosynthesis, transport and catabolism

R

   578

   11.44

    General function prediction only

S

   319

   6.32

    Function unknown

-

   1,258

   24.91

    Not in COGs

a The total is based on the total number of protein coding genes in the annotated genome.

Comparison with other Brevibacillus species genomes

Here, we compared the genome of B. massiliensis strain phRT with those of B. laterosporus strain LMG15441,B. brevis strain NBRC100599 and B. agri strain BAB-2500. The draft genome of B. massiliensis is smaller than those of B. laterosporus, B.agri and B. brevis (5.05, 5.14, 5.39 and 6.29 Mb, respectively). Brevibacillus massiliensis has a higher G+C content than Brevibacillus laterosporus and Brevibacillus brevis (53.10% vs 41.09% and 47.27% respectively) but smaller G+C content than Brevibacillus agri (53.10% vs 53.5%). B. massiliensis has a higher gene content than B. laterosporus (5,051 and 4,591, respectively) but lower than B. agri and B. brevis respectively (5.457 and 5.949 respectively). In addition, B. massiliensis shared 2,077, 2,500 and 2,453 orthologous genes with B. laterosporus, B. brevis and B. agri respectively. The average nucleotide sequence identity ranged from 67.17 to 78.81% among Brevibacillus species, and from 67.34 to 71.14% between B. massiliensis and other Brevibacillus species, thus confirming its new species status (Table 6).

Table 6

The numbers of orthologous protein shared between genomes (above diagonal)

   B. massiliensis

    B. laterosporus

  B. brevis

  B. agri

B. massiliensis

   5,051

    2,077

  2,500

  2,453

B. laterosporus

   67.34

    4,591

  2,403

  2,356

B. brevis

   69.36

    68.38

  5,949

  2,779

B. agri

   71.14

    67.17

  78.81

  5,457

average percentage similarity of nucleotides corresponding to orthologous protein shared between genomes (below diagonal) and the numbers of proteins per genome (bold) [49].

Conclusion

On the basis of phenotypic, phylogenetic and genomic analyses, we formally propose the creation of Brevibacillus massiliensis sp. nov. which currently contains strain phRT as its sole member; . This bacterial strain was originally isolated in Marseille, France.

Description of Brevibacillus massiliensis sp. nov.

Brevibacillus massiliensis (ma.si.li.en′sis. L. gen. masc. n. massiliensis, pertaining to Massilia, the ancient Roman name for Marseille, France, where the type strain was isolated).

Colonies are grey and 0.8 mm to 1 mm in diameter on blood-enriched Columbia agar. Cells are rod-shaped with a mean diameter of 0.74 µm and a mean length of 4.3µm with electron microscopy. Optimal growth is achieved aerobically. Weak growth was observed when cultures were gown under a 5% CO2. No growth is observed in microaerophilic or anaerobic conditions. Growth occurs between 30 and 45°C, with optimal growth occurring at 37°C. Cells stain Gram-positive, form endospores and are motile. Cells are positive for catalase, oxidase, alkaline phosphatase, cystine arylamidase, acid phosphatase, naphtol-AS-BI-phosphohydrolase and pyrazinamidase. Asaccharolytic. Cells are susceptible to penicillin G, amoxicillin, amoxicillin + clavulanic acid, ceftriaxone, imipenem, erythromycin, doxycycline, rifampicine, vancomycin, ciprofloxacin, gentamicin, nitrofurantoin and resistant to metronidazole and trimethoprim/sulfamethoxazole. The G+C content of the genome is 53.1%. The 16S rRNA and genome sequences are deposited in Genbank and EMBL under accession numbers JN837488 and CAGW00000000, respectively.

The type strain phRT (= CSUR P177 = DSM 25447) was isolated from the fecal flora of an obese patient in Marseille, France.

Declarations

Acknowledgements

The authors thank Mr. Julien Paganini at Xegen Company (Web Site) for automating the genomic annotation process. This study was funded by the Mediterranee Infection Foundation.


This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

  1. Lagier JC, Armougom F, Million M, Hugon P, Pagnier I, Robert C, Bittar F, Fournous G, Gimenez G and Maraninchi M. Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect. 2012; 18:1185-1193PubMed
  2. . Web Site
  3. Tindall BJ, Rossello-Mora R, Busse HJ, Ludwig W and Kampfer P. Notes on the characterization of prokaryote strains for taxonomic purposes. Int J Syst Evol Microbiol. 2010; 60:249-266 View ArticlePubMed
  4. Kokcha S, Mishra AK, Lagier JC, Million M, Leroy Q, Raoult D and Fournier PE. Non contiguous-finished genome sequence and description of Bacillus timonensis sp. nov. Stand Genomic Sci. 2012; 6:346-355 View ArticlePubMed
  5. Lagier JC, El Karkouri K, Nguyen TT, Armougom F, Raoult D and Fournier PE. Non-contiguous finished genome sequence and description of Anaerococcus senegalensis sp. nov. Stand Genomic Sci. 2012; 6:116-125 View ArticlePubMed
  6. Mishra AK, Gimenez G, Lagier JC, Robert C, Raoult D and Fournier PE. Non-contiguous finished genome sequence and description of Alistipes senegalensis sp. nov. Stand Genomic Sci. 2012; 6:304-314 View Article
  7. Lagier JC, Armougom F, Mishra AK, Ngyuen TT, Raoult D and Fournier PE. Non-contiguous finished genome sequence and description of Alistipes timonensis sp. nov. Stand Genomic Sci. 2012; 6:315-324PubMed
  8. Mishra AK, Lagier JC, Robert C, Raoult D and Fournier PE. Non-contiguous finished genome sequence and description of Clostridium senegalense sp. nov. Stand Genomic Sci. 2012; 6:386-395PubMed
  9. Mishra AK, Lagier JC, Robert C, Raoult D and Fournier PE. Non-contiguous finished genome sequence and description of Peptoniphilus timonensis sp. nov. [PubMed]. Stand Genomic Sci. 2012; 7:1-11 View ArticlePubMed
  10. Mishra AK, Lagier JC, Rivet R, Raoult D and Fournier PE. Non-contiguous finished genome sequence and description of Paenibacillus senegalensis sp. nov. Stand Genomic Sci. 2012; 7:70-81PubMed
  11. Lagier JC, Gimenez G, Robert C, Raoult D and Fournier PE. Non-contiguous finished genome sequence and description of Herbaspirillum massiliense sp. nov. Stand Genomic Sci. 2012; 7:200-209PubMed
  12. Roux V, El Karkouri K, Lagier JC, Robert C and Raoult D. Non-contiguous finished genome sequence and description of Kurthia massiliensis sp. nov. Stand Genomic Sci. 2012; 7:221-232 View ArticlePubMed
  13. Kokcha S, Ramasamy D, Lagier JC, Robert C, Raoult D and Fournier PE. Non-contiguous finished genome sequence and description of Brevibacterium senegalense sp. nov. Stand Genomic Sci. 2012; 7:233-245 View ArticlePubMed
  14. Ramasamy D, Kokcha S, Lagier JC, N’Guyen TT, Raoult D and Fournier PE. Non-contiguous finished genome sequence and description of Aeromicrobium massilense sp. nov. Stand Genomic Sci. 2012; 7:246-257 View ArticlePubMed
  15. Lagier JC, Ramasamy D, Rivet R, Raoult D and Fournier PE. Non-contiguous finished genome sequence and description of Cellulomonas massiliensis sp. nov. Stand Genomic Sci. 2012; 7:258-270 View ArticlePubMed
  16. Shida O, Takagi H, Kadowaki K and Komagata K. Proposal for two new genera, Brevibacillus gen. nov. and Aneurinibacillus gen. nov. Int J Syst Bacteriol. 1996; 46:939-946 View ArticlePubMed
  17. List of Prokaryotic names with Standing in Nomenclature. Web Site
  18. Logan NA, Forsyth G, Lebbe L, Goris J, Heyndrickx M, Balcaen A, Verhelst A, Falsen E, Ljungh A, Hansson HB and De Vos P. Polyphasic identification of Bacillus and Brevibacillus strains from clinical, dairy and industrial specimens and proposal of Brevibacillus invocatus sp. nov. Int J Syst Bacteriol. 2002; 52:953-966PubMed
  19. Goto K, Fujita R, Kato Y, Asahara M and Yokota A. Reclassification of Brevibacillus brevis strains NCIMB 13288 and DSM 6472 (=NRRL NRS-887) as Aneurinibacillus danicus sp. nov. and Brevibacillus limnophilus sp. nov. Int J Syst Evol Microbiol. 2004; 54:419-427 View ArticlePubMed
  20. Allan RN, Lebbe L, Heyrman J, De Vos P, Buchanan CJ and Logan NA. Brevibacillus levickii sp. nov. and Aneurinibacillus terranovensis sp. nov., two novel thermoacidophiles isolated from geothermal soils of northern Victoria Land, Antarctica. Int J Syst Evol Microbiol. 2005; 55:1039-1050 View ArticlePubMed
  21. Baek SH, Im WT, Oh WH, Lee JS, Oh HM and Lee ST. Brevibacillus ginsengisoli sp. nov., a denitrifying bacterium isolated from soil of a ginseng field. Int J Syst Evol Microbiol. 2006; 56:2665-2669 View ArticlePubMed
  22. Kim MK, Sathiyaraj S, Pulla RK and Yang DC. Brevibacillus panacihumi sp. nov., a beta-glucosidase-producing bacterium. Int J Syst Evol Microbiol. 2009; 59:1227-1231 View ArticlePubMed
  23. Choi MJ, Bae JY, Kim KY, Kang H and Cha CJ. Brevibacillus fluminis sp. nov., isolated from sediment of estuarine wetland. Int J Syst Evol Microbiol. 2010; 60:1595-1599 View ArticlePubMed
  24. Takebe F, Hirota K, Nodasaka Y and Yumoto I. Brevibacillus nitrificans sp. nov., a nitrifying bacterium isolated from a microbiological agent for enhancing microbial digestion in sewage treatment tanks. Int J Syst Evol Microbiol. 2012; 62:2121-2126 View ArticlePubMed
  25. Sharma V, Singh PK, Midha S, Ranjan M, Korpole S and Patil PB. Genome Sequence of Brevibacillus laterosporus Strain GI-9. J Bacteriol. 2012; 194:1279 View ArticlePubMed
  26. Andersson AM, Weiss N, Rainey F and Salkinoja-Salonen MS. Dust-borne bacteria in animal sheds, schools and children's day care centres. J Appl Microbiol. 1999; 86:622-634 View ArticlePubMed
  27. Lee L, Tin S and Kelley ST. Culture-independent analysis of bacterial diversity in a child-care facility. BMC Microbiol. 2007; 7:27 View ArticlePubMed
  28. Parvez N, Cornelius LK and Fader R. Brevibacillus brevis peritonitis. Am J Med Sci. 2009; 337:297-299 View ArticlePubMed
  29. Tabbara KF, Juffali F and Matossian RM. Bacillus laterosporus endophthalmitis. Arch Ophthalmol. 1977; 95:2187-2189 View ArticlePubMed
  30. Woese CR, Kandler O and Wheelis ML. Towards a natural system of organisms: proposal for the domains Archae, Bacteria, and Eukarya. Proc Natl Acad Sci USA. 1990; 87:4576-4579 View ArticlePubMed
  31. Gibbons NE and Murray RGE. Proposals Concerning the Higher Taxa of Bacteria. Int J Syst Bacteriol. 1978; 28:1-6 View Article
  32. Garrity GM, Holt JG. The Road Map to the Manual. In: Garrity GM, Boone DR, Castenholz RW (eds), Bergey's Manual of Systematic Bacteriology, Second Edition, Volume 1, Springer, New York, 2001, p. 119-169.
  33. Murray RGE. The Higher Taxa, or, a Place for Everything...? In: Holt JG (ed), Bergey's Manual of Systematic Bacteriology, First Edition, Volume 1, The Williams and Wilkins Co., Baltimore, 1984, p. 31-34.
  34. Validation list no. 132. List of new names and new combinations previously effectively, but not validly, published. Int J Syst Evol Microbiol. 2010; 60:469-472 View Article
  35. Ludwig W, Schleifer KH, Whitman WB. Class I. Bacilli class nov. In: De Vos P, Garrity G, Jones D, Krieg NR, Ludwig W, Rainey FA, Schleifer KH, Whitman WB (eds), Bergey's Manual of Systematic Bacteriology, Second Edition, Volume 3, Springer-Verlag, New York, 2009, p. 19-20.
  36. Skerman VBD and Sneath PHA. Approved list of bacterial names. Int J Syst Bacteriol. 1980; 30:225-420 View Article
  37. Prévot AR. In: Hauderoy P, Ehringer G, Guillot G, Magrou. J., Prévot AR, Rosset D, Urbain A (eds), Dictionnaire des Bactéries Pathogènes, Second Edition, Masson et Cie, Paris, 1953, p. 1-692.
  38. De Vos P, Ludwig W, Schleifer KH, Whitman WB. Family IV. Paenibacillaceae fam. nov. In: De Vos P, Garrity G, Jones D, Krieg NR, Ludwig W, Rainey FA, Schleifer KH, Whitman WB (eds), Bergey's Manual of Systematic Bacteriology, Second Edition, Volume 3, Springer-Verlag, New York, 2009, p. 269.
  39. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS and Eppig JT. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25:25-29 View ArticlePubMed
  40. Stackebrandt E and Ebers J. Taxonomic parameters revisited: tarnished gold standards. Microbiol Today. 2006; 33:152-155
  41. Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, Rolain JM and Raoult D. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis. 2009; 49:543-551 View ArticlePubMed
  42. Field D, Garrity G, Gray T, Morrison N, Selengut J, Sterk P, Tatusova T, Thomson N, Allen MJ and Angiuoli SV. The minimum information about a genome sequence (MIGS) specification. Nat Biotechnol. 2008; 26:541-547 View ArticlePubMed
  43. Prodigal. Web Site
  44. GenBank database. Web Site
  45. Lowe TM and Eddy SR. tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. Nucleic Acids Res. 1997; 25:955-964PubMed
  46. Lagesen K, Hallin P, Rodland EA, Staerfeldt HH, Rognes T and Ussery DW. RNAmmer: consistent and rapid annotation of ribosomal RNA genes. Nucleic Acids Res. 2007; 35:3100-3108 View ArticlePubMed
  47. Bendtsen JD, Nielsen H, von Heijne G and Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol. 2004; 340:783-795 View ArticlePubMed
  48. Krogh A, Larsson B, von Heijne G and Sonnhammer EL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol. 2001; 305:567-580 View ArticlePubMed
  49. Lechner M, Findeib S, Steiner L, Marz M, Stadler PF and Prohaska SJ. Proteinortho: Detection of (Co-)orthologs in large-scale analysis. BMC Bioinformatics. 2011; 12:124 View ArticlePubMed